CCoat
Phase 2- Indications
- Knee osteoarthritis
Company intelligence / Profile preview
Liposphere has developed a proprietary water-based biolubricant platform ("Coat by Liposphere") with applications in orthopedics and ophthalmology. Their lead orthopedic product is entering clinical trials to demonstrate superiority over saline in reducing friction and improving outcomes in osteoarthritis. Pilot studies have also been conducted with commercial partners on artificial joint implants. An ophthalmic formulation targets Dry Eye Syndrome with long-lasting lubricity effects[1][2].
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liposphere.